CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials

The CONSORT (Consolidated Standards of Reporting Trials) statement is used worldwide to improve the reporting of randomized, controlled trials. Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience.

[1]  Tom Starzl,et al.  THE LANCET , 1992, The Lancet.

[2]  Curtis L. Meinert,et al.  A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. , 1994, JAMA.

[3]  D. Rennie.  Reporting randomized controlled trials. An experiment and a call for responses from readers. , 1995, JAMA.

[4]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[5]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[6]  N. Black.  CONSORT , 1996, The Lancet.

[7]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[8]  S. Casswell,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999 .

[9]  G. Morrison,et al.  University of Pennsylvania School of Medicine. , 2000, Academic medicine : journal of the Association of American Medical Colleges.

[10]  David Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, Annals of Internal Medicine.

[11]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[12]  Douglas G Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[13]  Kenneth F Schulz,et al.  Blinding in randomised trials: hiding who got what , 2002, The Lancet.

[14]  Joy Melnikow,et al.  Reporting number needed to treat and absolute risk reduction in randomized controlled trials. , 2002, JAMA.

[15]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[16]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[17]  B. Djulbegovic,et al.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.

[18]  A. Walker,et al.  Improving the quality of reporting in randomised controlled trials. , 2004, Journal of wound care.

[19]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[20]  J. Ioannidis,et al.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.

[21]  R. Horton,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation research.

[22]  D. Altman,et al.  CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.

[23]  Clinical trial registration: a statement from the International Committee of Medical Journal Editors , 2004, The Lancet.

[24]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.

[25]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2004, Family practice.

[26]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[27]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.

[28]  Douglas G Altman,et al.  Epidemiology and reporting of randomised trials published in PubMed journals , 2005, The Lancet.

[29]  Peter C Gøtzsche,et al.  [Better reporting of harms in randomized trials: an extension of the CONSORT statement]. , 2005, Ugeskrift for laeger.

[30]  D. Moher,et al.  Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.

[31]  Douglas G Altman,et al.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.

[32]  David Moher,et al.  Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement , 2006, Annals of Internal Medicine.

[33]  David L Sackett,et al.  Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? , 2007, International journal of epidemiology.

[34]  Douglas G Altman,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, BMJ.

[35]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[36]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[37]  Douglas G Altman,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.

[38]  D. Moher,et al.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. , 2008, Annals of internal medicine.

[39]  Carl Heneghan,et al.  What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.

[40]  T. Wachs,et al.  CONSORT for reporting randomised trials in journal and conference abstracts , 2008 .

[41]  David Moher,et al.  [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration]. , 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[42]  D. Moher,et al.  CONSORT for reporting randomised trials in journal and conference abstracts , 2008, The Lancet.

[43]  J. Ioannidis,et al.  Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.

[44]  D. Moher,et al.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.

[45]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[46]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[47]  David Moher,et al.  CONSORT 2010 changes and testing blindness in RCTs , 2010, The Lancet.

[48]  Jeremy Howick,et al.  What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials , 2010, Annals of Internal Medicine.

[49]  D. Moher,et al.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. , 2012, International journal of surgery.

[50]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[51]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, BMC medicine.

[52]  S. Pocock,et al.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.